Literature DB >> 26695124

Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics.

Hye-yon Cho1, Kidong Kim2, Yong-Beom Kim2, Jae Hong No2.   

Abstract

AIM: The aim of this study was to identify the preoperative diagnostic findings suggestive of uterine sarcoma.
METHODS: We retrospectively reviewed the medical records of 31 patients with pathologically confirmed uterine sarcoma including leiomyosarcoma, endometrial stromal sarcoma, and undifferentiated sarcoma, between 2003 and 2011. The cases were matched by age, year of procedure (plus or minus 1 year), and surgeon, to controls (1:3 ratio) selected from all the patients who underwent hysterectomy for uterine myoma during the same period.
RESULTS: Uterine sarcomas had larger tumor size compared with leiomyoma on sonography (P = 0.006). There was no significant difference in the total number of masses found on ultrasonography (P = 0.066). On multivariate analysis increased neutrophil-to-lymphocyte ratio (NLR > 2.1), large tumor size (> 8.0 cm), and lower body mass index (BMI ≤ 20) were independent risk factors for uterine sarcoma (P = 0.014, 0.048, and 0.048, respectively). Sarcoma index was calculated by summing the number of risk factors. Higher sarcoma index was associated with increased risk of uterine sarcoma (0, 13.6%; 1, 21.7%; 2, 62.5%; 3, 100%).
CONCLUSION: Preoperative NLR, tumor size, and BMI could be useful for the discrimination of sarcoma from leiomyoma of uterus.
© 2015 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  body mass index; diagnosis; neutrophil-to-lymphocyte ratio; uterine sarcoma

Mesh:

Year:  2015        PMID: 26695124     DOI: 10.1111/jog.12915

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  8 in total

Review 1.  Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?

Authors:  Christine De Bruyn; Thaïs Baert; Thierry Van den Bosch; An Coosemans
Journal:  Curr Oncol Rep       Date:  2020-01-29       Impact factor: 5.075

Review 2.  Advances in the Preoperative Identification of Uterine Sarcoma.

Authors:  Junxiu Liu; Zijie Wang
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

3.  Uterine sarcoma: a clinical case and a literature review.

Authors:  Diana Bužinskienė; Saulius Mikėnas; Gražina Drąsutienė; Matas Mongirdas
Journal:  Acta Med Litu       Date:  2018

4.  Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid.

Authors:  Guorui Zhang; Xin Yu; Lan Zhu; Qingbo Fan; Honghui Shi; Jinghe Lang
Journal:  BMC Cancer       Date:  2020-06-03       Impact factor: 4.430

5.  Effect of tumor morcellation in patients with early uterine sarcoma: a multicenter study in Germany

Authors:  George Gitas; Kubilay Ertan; Sascha Baum; Achim Rody; George Pados; Kristina Wihlfahrt; Christos Kotanidis; Leila Allahqoli; Antonio Simone Laganà; Soteris Sommer; Ibrahim Alkatout
Journal:  J Turk Ger Gynecol Assoc       Date:  2022-03-10

6.  Safety and feasibility of laterally extended endopelvic resection for sarcoma in the female genital tract: a prospective cohort study.

Authors:  Soo Jin Park; Junhwan Kim; Jae-Weon Kim; Hee Seung Kim; Ga Won Yim
Journal:  Obstet Gynecol Sci       Date:  2022-06-27

7.  Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids.

Authors:  Innie Chen; Bianca Firth; Laura Hopkins; Olga Bougie; Ri-Hua Xie; Sukhbir Singh
Journal:  JSLS       Date:  2018 Jan-Mar       Impact factor: 2.172

8.  Preoperative Blood Inflammatory Markers for the Differentiation of Uterine Leiomyosarcoma from Leiomyoma.

Authors:  Dong Soo Suh; Yong Jung Song; Hyun-Jin Roh; Sang Hun Lee; Dae Hoon Jeong; Tae Hwa Lee; Kyung Un Choi; Ki Hyung Kim
Journal:  Cancer Manag Res       Date:  2021-06-24       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.